[Interpretation of the key updates in the 2022 European guideline on the management of neonatal respiratory distress syndrome]. / 2022年欧洲æ°çå¿å¼å¸çªè¿«ç»¼åå¾ç®¡çæåæ´æ°è¦ç¹è§£è¯».
Zhongguo Dang Dai Er Ke Za Zhi
; 25(8): 779-784, 2023 Aug 15.
Article
em Zh
| MEDLINE
| ID: mdl-37668023
With the deepening of clinical research, the management of neonatal respiratory distress syndrome (RDS) needs to be optimized and improved. This article aims to introduce the 2022 European guideline on the management of neonatal RDS, focusing on its key updates. The guide has optimized the management of risk prediction for preterm birth, maternal referral, application of prenatal corticosteroids, application of lung protective ventilation strategies, and general care for infants with RDS. The guideline is mainly applicable to the management of RDS in neonates with gestational age greater than 24 weeks.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Síndrome do Desconforto Respiratório do Recém-Nascido
/
Nascimento Prematuro
Tipo de estudo:
Guideline
/
Prognostic_studies
Limite:
Female
/
Humans
/
Newborn
/
Pregnancy
Idioma:
Zh
Revista:
Zhongguo Dang Dai Er Ke Za Zhi
Ano de publicação:
2023
Tipo de documento:
Article